These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 24424130)
1. The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids. Carrigan CN; Patel SA; Cox HD; Bolstad ES; Gerdes JM; Smith WE; Bridges RJ; Thompson CM Bioorg Med Chem Lett; 2014 Feb; 24(3):850-4. PubMed ID: 24424130 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport. Carrigan CN; Bartlett RD; Esslinger CS; Cybulski KA; Tongcharoensirikul P; Bridges RJ; Thompson CM J Med Chem; 2002 May; 45(11):2260-76. PubMed ID: 12014964 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors. Favre-Besse FC; Poirel O; Bersot T; Kim-Grellier E; Daumas S; El Mestikawy S; Acher FC; Pietrancosta N Eur J Med Chem; 2014 May; 78():236-47. PubMed ID: 24686010 [TBL] [Abstract][Full Text] [Related]
4. Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT). Patel SA; Nagy JO; Bolstad ED; Gerdes JM; Thompson CM Bioorg Med Chem Lett; 2007 Sep; 17(18):5125-8. PubMed ID: 17662605 [TBL] [Abstract][Full Text] [Related]
5. Virtual Fragment Screening Identification of a Quinoline-5,8-dicarboxylic Acid Derivative as a Selective JMJD3 Inhibitor. Giordano A; Del Gaudio F; Johansson C; Riccio R; Oppermann U; Di Micco S ChemMedChem; 2018 Jun; 13(12):1160-1164. PubMed ID: 29633584 [TBL] [Abstract][Full Text] [Related]
6. Inhibitor of the glutamate vesicular transporter (VGLUT). Thompson CM; Davis E; Carrigan CN; Cox HD; Bridges RJ; Gerdes JM Curr Med Chem; 2005; 12(18):2041-56. PubMed ID: 16101493 [TBL] [Abstract][Full Text] [Related]
7. Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system. Carrigan CN; Esslinger CS; Bartlett RD; Bridges RJ; Thompson CM Bioorg Med Chem Lett; 1999 Sep; 9(17):2607-12. PubMed ID: 10498218 [TBL] [Abstract][Full Text] [Related]
8. Some new quinoline-based mono and dicarboxylic acids. Ferranti A; Garuti L; Giovanninetti G; Roberti M; Varoli L Farmaco; 1993 Nov; 48(11):1547-53. PubMed ID: 8110365 [TBL] [Abstract][Full Text] [Related]
9. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Pietrancosta N; Kessler A; Favre-Besse FC; Triballeau N; Quentin T; Giros B; El Mestikawy S; Acher FC Bioorg Med Chem; 2010 Sep; 18(18):6922-33. PubMed ID: 20708942 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of quinoline dicarboxylic esters as biocompatible fluorescent tags. Laras Y; Hugues V; Chandrasekaran Y; Blanchard-Desce M; Acher FC; Pietrancosta N J Org Chem; 2012 Sep; 77(18):8294-302. PubMed ID: 22931204 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights. Hitt DM; Zwicker JD; Chao CK; Patel SA; Gerdes JM; Bridges RJ; Thompson CM Neurochem Res; 2021 Mar; 46(3):494-503. PubMed ID: 33398639 [TBL] [Abstract][Full Text] [Related]
12. LSP5-2157 a new inhibitor of vesicular glutamate transporters. Poirel O; Mamer LE; Herman MA; Arnulf-Kempcke M; Kervern M; Potier B; Miot S; Wang J; Favre-Besse FC; Brabet I; Laras Y; Bertrand HO; Acher F; Pin JP; Puel JL; Giros B; Epelbaum J; Rosenmund C; Dutar P; Daumas S; El Mestikawy S; Pietrancosta N Neuropharmacology; 2020 Mar; 164():107902. PubMed ID: 31811873 [TBL] [Abstract][Full Text] [Related]
13. Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Bartlett RD; Esslinger CS; Thompson CM; Bridges RJ Neuropharmacology; 1998 Jul; 37(7):839-46. PubMed ID: 9776380 [TBL] [Abstract][Full Text] [Related]
14. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3. Bunch L; Nielsen B; Jensen AA; Bräuner-Osborne H J Med Chem; 2006 Jan; 49(1):172-8. PubMed ID: 16392801 [TBL] [Abstract][Full Text] [Related]
15. VGLUT substrates and inhibitors: A computational viewpoint. Thompson CM; Chao CK Biochim Biophys Acta Biomembr; 2020 Dec; 1862(12):183175. PubMed ID: 31923412 [TBL] [Abstract][Full Text] [Related]
16. Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-). Ahmed SK; Etoga JL; Patel SA; Bridges RJ; Thompson CM Bioorg Med Chem Lett; 2011 Jul; 21(14):4358-62. PubMed ID: 21669531 [TBL] [Abstract][Full Text] [Related]
17. A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow. Tamura Y; Ogita K; Ueda T Neurochem Res; 2014 Jan; 39(1):117-28. PubMed ID: 24248859 [TBL] [Abstract][Full Text] [Related]
18. Bovine neuronal vesicular glutamate transporter activity is inhibited by ergovaline and other ergopeptines. Xue Y; Liao SF; Strickland JR; Boling JA; Matthews JC J Dairy Sci; 2011 Jul; 94(7):3331-41. PubMed ID: 21700019 [TBL] [Abstract][Full Text] [Related]
19. Modulation of GABA and glycine receptors in rat pyramidal hippocampal neurones by 3α5β-pregnanolone derivatives. Bukanova JV; Solntseva EI; Kolbaev SN; Kudova E Neurochem Int; 2018 Sep; 118():145-151. PubMed ID: 29886074 [TBL] [Abstract][Full Text] [Related]